Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Cardiovascular Effects of NSAIDs: A Review With a Focus on RA Patients
Author(s): Eirik Ikdahl , Anne Kerola , Eli Sollerud , et al Added: 1 year ago

Prevention & Chronic Conditions
ADA 25: Clinical Implications of STRIDE for Endocrinologists
Author(s): Added: 10 months ago
ADA 2025 - We are joined by Dr Alice Cheng (University of Toronto, Toronto, CA) to discuss the clinical implications of STRIDE (NCT04560998). The placebo-controlled study investigated whether semaglutide with standard-of-care treatment has an effect on walking ability in patients with PAD and T2D. The primary outcome measure was the change in maximum walking distance on a constant load treadmill… View more

Cardiovascular Kidney Metabolic

Vascular Disease and Surgery
Author(s): Chim C Lang Added: 11 months ago
Prof Chim Lang discusses his upcoming special focus for ECR. The collection will include contributions from Dr Emily Morris, Dr John Wilding, Dr Samira Bell, Dr Bianca Rocca, and Dr Ramzi Ajjan, the collection explores the global burden of obesity, its impact on heart failure and kidney disease, and emerging therapeutic strategies—including the evolving role of GLP-1 receptor agonists. View more

Cardiovascular Kidney Metabolic
30th Annual Meeting of the ISCP
Author(s): Daniel García Iglesias , Fernando López Iglesias , Rodrigo Ariel di Massa , et al Added: 1 month ago

Imaging & Diagnostics

Prevention & Chronic Conditions
Obesity in Focus: Implications for Heart Failure, Kidney Disease, and Pharmacology
Author(s): Chim C Lang , Bianca Rocca , Samira Bell Added: 8 months ago
In this short discussion, join Prof Chim Lang (University of Dundee, Dundee, UK), Guest Editor of the upcoming Special Focus on Obesity in Focus, Prof Bianca Rocca (LUM University, Casamassima, IT) and Dr Samira Bell (University of Dundee, Dundee, UK) to discover the implications of obesity on heart failure, kidney disease, and pharmacology.This conversation sets the stage for the upcoming… View more

Cardiovascular Kidney Metabolic

Heart Failure
AHA 25: HFpEF as an Adipose Tissue Disorder
Author(s): Milton Packer Added: 6 months ago
AHA Scientific Sessions 2025 - Dr Milton Packer (Baylor University Medical Center, US) joins us to discuss his novel unifying hypothesis that heart failure with preserved ejection fraction arises primarily from visceral adipose tissue dysfunction and altered adipokine signaling, rather than as a heterogeneous disorder driven by multiple comorbidities.Interview Questions:Can you explain the core… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Preterm Birth and Maternal Cardiovascular Risk
Author(s): Jorge Segovia-Reyes , Andrea Iboleon-Jimenez , María Jiménez-Salva , et al Added: 2 weeks ago

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Frailty and Cardiovascular Risk
Author(s): Nicholas R Evans , Shiv Bhakta , Claudia Zeicu , et al Added: 2 weeks ago

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Definitions and Implications of Shock Diagnosis and Therapy with Dr Frederick Welt
Author(s): Frederick Welt Added: 7 months ago
Learn about the definition and implications of a shock diagnosis and systems of care and the role of the shock team from Dr Frederick Welt (University of Utah, US).This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr Frederick… View more

Intervention

MI/ACS